Eurobio Scientific SA (ALERS)

Currency in EUR
22.00
-0.20(-0.90%)
Closed·
Advertisement
ALERS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
21.6022.40
52 wk Range
20.4025.95
Key Statistics
Prev. Close
22.2
Open
22.4
Day's Range
21.6-22.4
52 wk Range
20.4-25.95
Volume
1.26K
Average Volume (3m)
1.59K
1-Year Change
-12.6984%
Book Value / Share
18.27
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALERS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
30.00
Upside
+36.36%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Eurobio Scientific SA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 30.00
(+36.36% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
10/04/2026
EPS / Forecast
0.24 / --
Revenue / Forecast
88.2M / --
EPS Revisions
Last 90 days

Compare ALERS to Peers and Sector

Metrics to compare
ALERS
Peers
Sector
Relationship
P/E Ratio
44.7x−2.3x−0.4x
PEG Ratio
2.220.030.00
Price/Book
1.2x1.4x2.6x
Price / LTM Sales
1.3x3.8x3.0x
Upside (Analyst Target)
36.4%94.4%57.3%
Fair Value Upside
Unlock−0.8%8.9%Unlock

Eurobio Scientific Société anonyme engages in research, development, and marketing specialty diagnostic products in the areas of transplantation, infectious diseases, autoimmunity, oncology, and life sciences. The company produces and markets transport and preservation media for corneal grafts; AlloMap, for heart transplant follow up; cell culture media, molecular biology reagents, contract manufacturing service, and proprietary antibodies; TQS (Tetanus Quick Stick), a rapid test used in emergency departments or pharmacies to assess the vaccination status or immune protection of patients against tetanus; EBX molecular biology ranges in the field of infectious diseases; and EndoPredict range, a second-generation multigene expression test for postmenopausal women with early-stage breast cancer, ER positive, and HER2 negative, as well as Prolaris. It also provides GenDx, EurobioPlex, FungiLine, Biosafety PKA, and immunology products. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.

Employees
343
Market
France

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
9.82M97.49%217.91M
Public Companies & Retail Investors
252.63K2.51%5.61M
Total
10.07M100.00%223.52M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
EB Development91.62%9,224,652204,787
Eximium SAS5.87%590,99613,120

People Also Watch

24.10
KOF
+0.42%
23.85
LBIRD
-1.45%
0.940
ALBIO
+5.62%
4.765
ALMDT
-1.75%

FAQ

What Is the Eurobio Scientific (Paris: ALERS) Share Price Today?

The Eurobio Scientific stock price today is 22.00 EUR.

What Stock Exchange Does Eurobio Scientific (ALERS) Trade On?

Eurobio Scientific is listed and trades on the Paris Stock Exchange.

What Is the Ticker (Stock Symbol) for Eurobio Scientific?

The stock symbol (also called a 'ticker') for Eurobio Scientific is "ALERS."

What Is the Current Eurobio Scientific Market Capitalisation?

As of today, Eurobio Scientific (Paris: ALERS) market cap is 221.50M EUR.

What Is Eurobio Scientific's (ALERS) Earnings Per Share (TTM)?

The Eurobio Scientific EPS is currently 0.47 (Trailing Twelve Months).

Is ALERS a Buy or Sell From a Technical Analyst Perspective?

Based on today's Eurobio Scientific moving averages and other technical indicators, the daily buy/sell signal for ALERS stock is Strong Sell.

How Many Times Has Eurobio Scientific Stock Split?

Eurobio Scientific has split 1 times. (See the ALERS stock split history page for full effective split date and price information.)

How Many Employees Does Eurobio Scientific Have?

Eurobio Scientific has 343 employees, based on their latest Companies House report.

What is the current trading status of Eurobio Scientific (Paris: ALERS)?

As of 25/06/2026, Eurobio Scientific (ALERS) is trading at a share price of 22.00 EUR, with a previous close of 22.20 EUR. The stock has fluctuated within a day range of 21.60 EUR to 22.40 EUR, while its 52-week range spans from 20.40 EUR to 25.95 EUR.

What Is Eurobio Scientific (ALERS) Price Target According to Analysts?

The average 12-month price target for Eurobio Scientific is 30.00 EUR, with a high estimate of 30 EUR and a low estimate of 30 EUR. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +36.36% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.